Adient (NYSE:ADNT – Get Free Report) had its price objective upped by investment analysts at Barclays from $50.00 to $55.00 in a note issued to investors on Thursday, Marketbeat.com reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective points to a potential upside of 24.32% from the company’s current price. […]